Brenda E. Ryman

4.1k total citations
70 papers, 3.0k citations indexed

About

Brenda E. Ryman is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Rheumatology. According to data from OpenAlex, Brenda E. Ryman has authored 70 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 12 papers in Radiology, Nuclear Medicine and Imaging and 11 papers in Rheumatology. Recurrent topics in Brenda E. Ryman's work include Lipid Membrane Structure and Behavior (11 papers), Radiopharmaceutical Chemistry and Applications (10 papers) and Glycogen Storage Diseases and Myoclonus (10 papers). Brenda E. Ryman is often cited by papers focused on Lipid Membrane Structure and Behavior (11 papers), Radiopharmaceutical Chemistry and Applications (10 papers) and Glycogen Storage Diseases and Myoclonus (10 papers). Brenda E. Ryman collaborates with scholars based in United Kingdom, United States and Germany. Brenda E. Ryman's co-authors include Gregory Gregoriadis, D. A. J. Tyrrell, C M Colley, Harish M. Patel, Vernon J. Richardson, Harish M. Patel, T. N. Palmer, P. D. Leathwood, T D Heath and R. F. Jewkes and has published in prestigious journals such as Nature, The Lancet and Diabetes.

In The Last Decade

Brenda E. Ryman

70 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brenda E. Ryman United Kingdom 27 1.6k 771 441 314 293 70 3.0k
Hugues J.‐P. Ryser United States 27 1.8k 1.1× 313 0.4× 265 0.6× 91 0.3× 390 1.3× 55 3.3k
Milton B. Yatvin United States 25 1.6k 1.0× 880 1.1× 321 0.7× 117 0.4× 93 0.3× 112 3.1k
Andrew S. Janoff United States 29 1.5k 1.0× 863 1.1× 153 0.3× 172 0.5× 179 0.6× 50 2.7k
Yoshinori Katō Japan 31 1.4k 0.9× 562 0.7× 785 1.8× 310 1.0× 224 0.8× 117 3.2k
Motoharu Iwatsuru Japan 23 1.3k 0.8× 1.0k 1.3× 258 0.6× 195 0.6× 94 0.3× 63 2.1k
Harish M. Patel United Kingdom 13 864 0.5× 433 0.6× 108 0.2× 292 0.9× 148 0.5× 19 1.6k
Heidi Wunderli‐Allenspach Switzerland 33 1.4k 0.9× 248 0.3× 139 0.3× 251 0.8× 259 0.9× 62 2.8k
Tudor Arvinte Switzerland 26 1.5k 1.0× 278 0.4× 394 0.9× 120 0.4× 127 0.4× 60 2.1k
A. Trouet Belgium 21 749 0.5× 220 0.3× 176 0.4× 90 0.3× 123 0.4× 76 1.6k
Tracy Robson United Kingdom 40 1.8k 1.2× 204 0.3× 393 0.9× 224 0.7× 518 1.8× 116 3.8k

Countries citing papers authored by Brenda E. Ryman

Since Specialization
Citations

This map shows the geographic impact of Brenda E. Ryman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brenda E. Ryman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brenda E. Ryman more than expected).

Fields of papers citing papers by Brenda E. Ryman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brenda E. Ryman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brenda E. Ryman. The network helps show where Brenda E. Ryman may publish in the future.

Co-authorship network of co-authors of Brenda E. Ryman

This figure shows the co-authorship network connecting the top 25 collaborators of Brenda E. Ryman. A scholar is included among the top collaborators of Brenda E. Ryman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brenda E. Ryman. Brenda E. Ryman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Patel, Harish M., Nayyar Parvez, Jim A. Field, & Brenda E. Ryman. (1983). Lytic effect of heparin on liposomes: possible mechanism of lysis of red blood cells by heparin. Bioscience Reports. 3(1). 39–46. 4 indexed citations
2.
Patel, Harish M., et al.. (1983). Inhibitory effect of cholesterol on the uptake of liposomes by liver and spleen. Biochimica et Biophysica Acta (BBA) - General Subjects. 761(2). 142–151. 79 indexed citations
3.
Richardson, Vernon J. & Brenda E. Ryman. (1982). Effect of liposomally trapped antitumour drugs on a drug-resistant mouse lymphoma in vivo. British Journal of Cancer. 45(4). 552–558. 10 indexed citations
4.
Souhami, Robert L., Harish M. Patel, & Brenda E. Ryman. (1981). The effect of reticuloendothelial blockade on the blood clearance and tissue distribution of liposomes. Biochimica et Biophysica Acta (BBA) - General Subjects. 674(3). 354–371. 86 indexed citations
5.
Richardson, Vernon J., Brenda E. Ryman, R. F. Jewkes, et al.. (1979). Tissue distribution and tumour localization of 99m-technetium-labelled liposomes in cancer patients. British Journal of Cancer. 40(1). 35–43. 62 indexed citations
6.
Richardson, Vernon J., K. Jeyasingh, R. F. Jewkes, Brenda E. Ryman, & Martin H.N. Tattersall. (1978). Possible tumor localization of Tc-99m-labeled liposomes: effects of lipid composition, charge, and liposome size.. PubMed. 19(9). 1049–54. 50 indexed citations
7.
Richardson, Vernon J., K. Jeyasingh, R. F. Jewkes, Brenda E. Ryman, & Martin H.N. Tattersall. (1977). Properties of [99mTc] Technetium-Labelled Liposomes in Normal and Tumour-Bearing Rats. Biochemical Society Transactions. 5(1). 290–291. 74 indexed citations
8.
Tyrrell, D. A. J., Brenda E. Ryman, Barry R. Keeton, & Victor Dubowitz. (1976). Use of liposomes in treating type II glycogenosis.. BMJ. 2(6027). 88–88. 32 indexed citations
9.
Colley, C M & Brenda E. Ryman. (1976). The liposome: from membrane model to therapeutic agent. Trends in Biochemical Sciences. 1(9). 203–205. 3 indexed citations
10.
Colley, C M & Brenda E. Ryman. (1976). The liposome: From membrane model to therapeutic agent. Trends in Biochemical Sciences. 1(3). 203–205. 9 indexed citations
11.
Colley, C M & Brenda E. Ryman. (1975). Liposomes as Carriers in vivo for Methotrexate. Biochemical Society Transactions. 3(1). 157–159. 55 indexed citations
12.
Gregoriadis, Gregory & Brenda E. Ryman. (1973). Tritiation of glycoproteins. Biochemical and Biophysical Research Communications. 52(4). 1134–1140. 5 indexed citations
13.
Gregoriadis, Gregory & Brenda E. Ryman. (1972). Lysosomal localization of β-fructofuranosidase-containing liposomes injected into rats. Some implications in the treatment of genetic disorders. Biochemical Journal. 129(1). 123–133. 208 indexed citations
14.
Ryman, Brenda E., et al.. (1971). High liver glycogen in hereditary fructose intolerance. Gut. 12(11). 929–932. 5 indexed citations
15.
Palmer, T. Norman & Brenda E. Ryman. (1971). The regulatory role of amylo‐1,6‐glucosidase/oligo‐1,4→1,4‐glucantransferase in liver glycogen metabolism. FEBS Letters. 18(2). 277–279. 2 indexed citations
16.
Ryman, Brenda E., et al.. (1971). New Aspects of Glycogen Metabolism. Advances in enzymology and related areas of molecular biology/Advances in enzymology and related subjects. 34. 285–443. 52 indexed citations
17.
Leathwood, P. D. & Brenda E. Ryman. (1970). The use of skin biopsy in the diagnosis of the glycogen-storage diseases. Biochemical Journal. 117(2). 34P–34P. 4 indexed citations
18.
Palmer, T. Norman & Brenda E. Ryman. (1968). The action pattern of amylomaltase. FEBS Letters. 1(1). 1–3. 29 indexed citations
19.
Ryman, Brenda E., et al.. (1952). Some effects of cocaine on the metabolism of Saccharomyces cerevisiae. Biochemical Journal. 50(4). 570–573. 7 indexed citations
20.
Ryman, Brenda E., et al.. (1951). Reversion of the Effect of Vitamin B1 on Yeast Fermentation as a Result of Growth in the Presence of Cocaine. Nature. 167(4254). 770–770. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026